Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tanaka

Showing results (771-780 of 838) with videos related to

Pageof 84
Sort By:
Clinical Lung Cancer|August 13, 2024
Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)Hayato Kawachi, Motohiro Tamiya, Yuko Oya, et al.
BMC Cancer|April 2, 2021
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter studyKazutaka Hosoya, Daichi Fujimoto, Takeshi Morimoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 12, 2022
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosisYuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, et al.
Biochemical and Biophysical Research Communications|October 31, 2025
PAGE4, upregulated in a novel iPSC-derived hepatoblastoma model, promotes hepatoblastoma progressionIssei Kawakita, Shohei Honda, Yuta Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 11, 2026
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis BEmi Sometani, Kazuhiro Murai, Hayato Hikita, et al.
British Journal of Neurosurgery|September 23, 2021
Pseudohypoxic brain swelling and secondary hydrocephalus with pseudomeningocele after lumbar surgery: a case reportYoshinari Miyaoka, Masashi Uehara, Hiroki Oba, et al.
Journal of Anesthesia|March 18, 2024
Incidence of sodium-glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort studyHiroyuki Seki, Norifumi Kuratani, Toshiya Shiga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogsEmi Sometani, Hayato Hikita, Kazuhiro Murai, et al.
The Journal of Experimental Medicine|December 1, 2022
Construction of a T cell receptor signaling range for spontaneous development of autoimmune diseaseAtsushi Tanaka, Shinji Maeda, Takashi Nomura, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2025
Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort studyNao Shoshihara, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Pageof 84

Showing results (771-780 of 838) with videos related to

Sort By:
Pageof 84
Clinical Lung Cancer|August 13, 2024
Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)Hayato Kawachi, Motohiro Tamiya, Yuko Oya, et al.
BMC Cancer|April 2, 2021
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter studyKazutaka Hosoya, Daichi Fujimoto, Takeshi Morimoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 12, 2022
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosisYuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, et al.
Biochemical and Biophysical Research Communications|October 31, 2025
PAGE4, upregulated in a novel iPSC-derived hepatoblastoma model, promotes hepatoblastoma progressionIssei Kawakita, Shohei Honda, Yuta Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 11, 2026
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis BEmi Sometani, Kazuhiro Murai, Hayato Hikita, et al.
British Journal of Neurosurgery|September 23, 2021
Pseudohypoxic brain swelling and secondary hydrocephalus with pseudomeningocele after lumbar surgery: a case reportYoshinari Miyaoka, Masashi Uehara, Hiroki Oba, et al.
Journal of Anesthesia|March 18, 2024
Incidence of sodium-glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort studyHiroyuki Seki, Norifumi Kuratani, Toshiya Shiga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogsEmi Sometani, Hayato Hikita, Kazuhiro Murai, et al.
The Journal of Experimental Medicine|December 1, 2022
Construction of a T cell receptor signaling range for spontaneous development of autoimmune diseaseAtsushi Tanaka, Shinji Maeda, Takashi Nomura, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2025
Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort studyNao Shoshihara, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Pageof 84